Masato Ishigami

5.3k total citations · 1 hit paper
70 papers, 4.2k citations indexed

About

Masato Ishigami is a scholar working on Surgery, Endocrinology, Diabetes and Metabolism and Molecular Biology. According to data from OpenAlex, Masato Ishigami has authored 70 papers receiving a total of 4.2k indexed citations (citations by other indexed papers that have themselves been cited), including 40 papers in Surgery, 29 papers in Endocrinology, Diabetes and Metabolism and 22 papers in Molecular Biology. Recurrent topics in Masato Ishigami's work include Lipoproteins and Cardiovascular Health (30 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (26 papers) and Peroxisome Proliferator-Activated Receptors (17 papers). Masato Ishigami is often cited by papers focused on Lipoproteins and Cardiovascular Health (30 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (26 papers) and Peroxisome Proliferator-Activated Receptors (17 papers). Masato Ishigami collaborates with scholars based in Japan, United States and Germany. Masato Ishigami's co-authors include Shizuya Yamashita, Yūji Matsuzawa, Naohiko Sakai, Ken‐ichi Hirano, Makoto Nishida, Shinji Kihara, Akifumi Matsuyama, Tohru Funahashi, Kaoru Kameda-Takemura and Hiroshi Kuriyama and has published in prestigious journals such as Journal of Biological Chemistry, Circulation and Journal of Clinical Investigation.

In The Last Decade

Masato Ishigami

68 papers receiving 4.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Adipocyte-Derived Plasma Protein, Adiponectin, Suppresses Lipid Accumulation and Class A Scavenger Receptor Expression in Human Monocyte-Derived Macrophages

2001 1.1k citations Shinji Kihara, Makoto Nishida et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Masato Ishigami Japan	33	1.6k	1.5k	1.2k	1.1k	1.0k	70	4.2k
Naohiko Sakai Japan	37	2.2k 1.4×	1.2k 0.8×	1.8k 1.5×	1.2k 1.2×	1.1k 1.1×	90	4.8k
Marcello Arca Italy	43	2.9k 1.8×	1.1k 0.8×	2.1k 1.8×	1.3k 1.2×	2.1k 2.1×	215	6.3k
Hayes M. Dansky United States	32	1.8k 1.1×	601 0.4×	999 0.9×	843 0.8×	831 0.8×	51	3.9k
Ewa Ninio France	37	1.2k 0.7×	748 0.5×	570 0.5×	1.4k 1.3×	576 0.6×	103	4.1k
Marit Westerterp Netherlands	40	1.8k 1.1×	946 0.6×	774 0.7×	1.9k 1.8×	641 0.6×	77	5.1k
Richard Lee United States	32	1.7k 1.1×	695 0.5×	968 0.8×	2.5k 2.4×	998 1.0×	75	5.1k
John F. Moorhead United Kingdom	35	1.1k 0.7×	902 0.6×	615 0.5×	1.2k 1.2×	366 0.4×	71	3.9k
Naoki Terasaka Japan	14	1.4k 0.9×	916 0.6×	477 0.4×	1.0k 0.9×	520 0.5×	17	2.8k
Wilfried Le Goff France	34	2.2k 1.4×	626 0.4×	1.4k 1.2×	1.2k 1.1×	567 0.6×	110	4.1k
Adam E. Mullick United States	32	1.0k 0.6×	638 0.4×	885 0.8×	1.5k 1.4×	966 1.0×	79	4.0k

Countries citing papers authored by Masato Ishigami

Since Specialization

Citations

This map shows the geographic impact of Masato Ishigami's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Masato Ishigami with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Masato Ishigami more than expected).

Fields of papers citing papers by Masato Ishigami

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Masato Ishigami. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Masato Ishigami. The network helps show where Masato Ishigami may publish in the future.

Co-authorship network of co-authors of Masato Ishigami

This figure shows the co-authorship network connecting the top 25 collaborators of Masato Ishigami. A scholar is included among the top collaborators of Masato Ishigami based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Masato Ishigami. Masato Ishigami is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Goto, Kōichi, Yoshimasa Shiraishi, Haruyasu Murakami, et al.. (2023). Phase 1 study of DS‐1205c combined with gefitinib for EGFR mutation‐positive non‐small cell lung cancer. Cancer Medicine. 12(6). 7090–7104. 6 indexed citations

Yasui, Hisateru, Atsushi Takeno, Hiroki Hara, et al.. (2022). Prospective analysis of the expression status of FGFR2 and HER2 in colorectal and gastric cancer populations: DS-Screen Study. International Journal of Colorectal Disease. 37(6). 1393–1402. 8 indexed citations

Nishio, Makoto, Isamu Okamoto, Haruyasu Murakami, et al.. (2020). 570P A first-in-human phase I study of the AXL inhibitor DS-1205c in combination with gefitinib in subjects with EGFR-mutant NSCLC. Annals of Oncology. 31. S488–S488. 8 indexed citations

Ishigami, Masato, et al.. (2018). Temporary sequestration of cholesterol and phosphatidylcholine within extracellular domains of ABCA1 during nascent HDL generation. Scientific Reports. 8(1). 6170–6170. 37 indexed citations

Ishigami, Masato, Kohjiro Nagao, Yasuhisa Kimura, et al.. (2013). ATPase activity of nucleotide binding domains of human MDR3 in the context of MDR1. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids. 1831(4). 683–690. 15 indexed citations

Masuda, Daisaku, Kenichi Tsujii, Miwako Inagaki, et al.. (2012). Correlation of fasting serum apolipoprotein B‐48 with coronary artery disease prevalence. European Journal of Clinical Investigation. 42(9). 992–999. 48 indexed citations

Masuda, Daisaku, Naohiko Sakai, Ryota Kawase, et al.. (2011). Fasting Serum Apolipoprotein B-48 Can be a Marker of Postprandial Hyperlipidemia. Journal of Atherosclerosis and Thrombosis. 18(12). 1062–1070. 40 indexed citations

Nakatani, Kazuhiro, Daisaku Masuda, Tomoko Oya, et al.. (2011). Serum apolipoprotein B-48 levels are correlated with carotid intima-media thickness in subjects with normal serum triglyceride levels. Atherosclerosis. 218(1). 226–232. 31 indexed citations

Masuda, Daisaku, Yumiko Nakagawa-Toyama, Kazuhiro Nakatani, et al.. (2009). Ezetimibe improves postprandial hyperlipidaemia in patients with type IIb hyperlipidaemia. European Journal of Clinical Investigation. 39(8). 689–698. 76 indexed citations

10.

Masuda, Daisaku, Ken‐ichi Hirano, Hiroyuki Oku, et al.. (2008). Chylomicron remnants are increased in the postprandial state in CD36 deficiency. Journal of Lipid Research. 50(5). 999–1011. 87 indexed citations

11.

Yamashita, Shizuya, Mitsuhiro Nakamura, Hiroyuki Oku, et al.. (2008). Evaluation of a Homogeneous Assay for Measuring LDL-cholesterol in Hyperlipidemic Serum Specimens. Journal of Atherosclerosis and Thrombosis. 15(2). 82–86. 12 indexed citations

12.

Tsubakio‐Yamamoto, Kazumi, Fumihiko Matsuura, Masahiro Koseki, et al.. (2008). Adiponectin prevents atherosclerosis by increasing cholesterol efflux from macrophages. Biochemical and Biophysical Research Communications. 375(3). 390–394. 109 indexed citations

13.

Matsuura, Fumihiko, Hiroyuki Oku, Masahiro Koseki, et al.. (2007). Adiponectin accelerates reverse cholesterol transport by increasing high density lipoprotein assembly in the liver. Biochemical and Biophysical Research Communications. 358(4). 1091–1095. 126 indexed citations

14.

Yamashita, Shizuya, Ken‐ichi Hirano, Takahiro Kuwasako, et al.. (2006). Physiological and pathological roles of a multi-ligand receptor CD36 in atherogenesis; insights from CD36-deficient patients. Molecular and Cellular Biochemistry. 299(1-2). 19–22. 115 indexed citations

15.

Tsujii, Kenichi, Ken‐ichi Hirano, Zhongyan Zhang, et al.. (2003). Measurement of Cholesterol Efflux from Monocyte-Derived Macrophages of Patients with Llpid Disorders and Atherosclerotic Cardiovascular Diseases. Japanese Circulation Journal-english Edition. 67. 449. 1 indexed citations

16.

Yamashita, Shizuya, Masato Ishigami, Naohiko Sakai, et al.. (2002). Decreased microsomal triglyceride transfer protein activity contributes to initiation of alcoholic liver steatosis in rats. Journal of Hepatology. 36(2). 157–162. 71 indexed citations

17.

Ohama, Tohru, Ken‐ichi Hirano, Zhongyan Zhang, et al.. (2002). Dominant expression of ATP-binding cassette transporter-1 on basolateral surface of Caco-2 cells stimulated by LXR/RXR ligands. Biochemical and Biophysical Research Communications. 296(3). 625–630. 60 indexed citations

18.

Matsuura, Fumihiko, Shizuya Yamashita, Ken‐ichi Hirano, et al.. (1999). Activation of monocytes in vivo causes intracellular accumulation of lipoprotein-derived lipids and marked hypocholesterolemia—a possible pathogenesis of necrobiotic xanthogranuloma. Atherosclerosis. 142(2). 355–365. 48 indexed citations

19.

Yamashita, Shizuya, Takeshi Arai, Ken‐ichi Hirano, et al.. (1996). Molecular Disorders of Cholesteryl Ester Transfer Protein. Journal of Atherosclerosis and Thrombosis. 3(1). 1–11. 6 indexed citations

20.

Nozaki, Satoshi, Hirokazu Kashiwagi, Shizuya Yamashita, et al.. (1995). Reduced uptake of oxidized low density lipoproteins in monocyte-derived macrophages from CD36-deficient subjects.. Journal of Clinical Investigation. 96(4). 1859–1865. 273 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact